Simplexa® Flu A/B & RSV Kit

Reliable detection and differentiation of influenza A virus, influenza B virus and RSV

KIT for Infectious Diseases

Overview

Background

The CDC estimates that influenza has resulted in up to 35.6 million illnesses, 710,000 hospitalizations, and as many as 56,000 deaths annually since 2010.1

Respiratory syncytial virus (RSV) infection is more prevalent in infants and toddlers and is a leading cause of hospitalization in this age group, but RSV also causes disease in adults that can be severe in certain populations.2

1. https://www.cdc.gov/flu/about/disease/burden.htm
2. MOL2650, Simplexa® Flu A/B & RSV Direct Kit Product Insert, Rev. F.

Why to choose it

Capable of running 94 patient samples at the same time.

Benefits

Reliability

Reliable performance that you can count on

greater than 98% specificity

Simplexa® Flu A/B & RSV assay has 100% sensitivity and greater than 98% specificity.

Simplexa® Flu A/B and Culture/DFA Clinical Agreement
Influenza A
Clinical Agreement Prospective
Samples
Retrospective
Samples
Clinical Agreement Sensitivity Prospective
Samples
 100%
Retrospective
Samples
 100%
Clinical Agreement Specificity Prospective
Samples
 99.3%
Retrospective
Samples
 100%
Influenza B
Clinical Agreement Prospective
Samples
Retrospective
Samples
Clinical Agreement Sensitivity Prospective
Samples
 100%
Retrospective
Samples
 100%
Clinical Agreement Specificity Prospective
Samples
 99.8%
Retrospective
Samples
 100%
RSV
Clinical Agreement Prospective
Samples
Retrospective
Samples
Clinical Agreement Sensitivity Prospective
Samples
 98.0%
Retrospective
Samples
 100%
Clinical Agreement Specificity Prospective
Samples
 96.9%
Retrospective
Samples
 96.0%


Ordering info

Product Code Reactions
Product

Simplexa® Flu A/B & RSV Kit

Code MOL2600 Reactions 100

Our repository

All the answers you need.
Access our database to find:
instructions for use, safety data sheets,
assay protocols and more.

Access our repository